PL
VRTX icon

Perpetual Ltd’s Vertex Pharmaceuticals VRTX Stock Holding History

Perpetual Ltd’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$942K Buy
1,897
+60
+3% +$26.6K 0.01% 237
2026
Q1 		$820K Buy
1,837
+201
+12% +$93.7K 0.01% 241
2025
Q4 		$742K Buy
+1,636
New +$705K 0.01% 255
2025
Q3 		– Sell
-679
Closed -$302K – 454
2025
Q2 		$302K Buy
679
+56
+9% +$25.8K ﹤0.01% 378
2025
Q1 		$302K Buy
+623
New +$290K ﹤0.01% 374
2024
Q4 		– Sell
-167,221
Closed -$77.8M – 459
2024
Q3 		$77.8M Sell
167,221
-2,954
-2% -$1.42M 0.84% 42
2024
Q2 		$79.8M Sell
170,175
-27,176
-14% -$11.8M 0.87% 36
2024
Q1 		$82.5M Sell
197,351
-10,352
-5% -$4.38M 0.81% 46
2023
Q4 		$84.5M Sell
207,703
-59,803
-22% -$22.1M 0.87% 39
2023
Q3 		$93M Sell
267,506
-2,976
-1% -$1.04M 0.96% 32
2023
Q2 		$95.2M Sell
270,482
-32,747
-11% -$11M 0.82% 38
2023
Q1 		$95.5M Buy
+303,229
New +$90.9M 0.83% 41
2020
Q3 		$6.76M Sell
24,850
-1,890
-7% -$521K 0.49% 79
2020
Q2 		$7.76M Sell
26,740
-10,170
-28% -$2.76M 0.73% 34
2020
Q1 		$8.78M Buy
+36,910
New +$8.47M 1.24% 13
2015
Q1 		– Sell
-23,793
Closed -$2.83M – 217
2014
Q4 		$2.83M Sell
23,793
-6,700
-22% -$755K 0.33% 106
2014
Q3 		$3.42M Sell
30,493
-9,467
-24% -$901K 0.37% 86
2014
Q2 		$3.78M Buy
+39,960
New +$2.8M 0.33% 76

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Perpetual Ltd's VRTX Position: Q2 2026 in Review

Perpetual Ltd increased its Vertex Pharmaceuticals (VRTX) stake by 3.3% in Q2 2026, buying an estimated $26.6K and bringing the position to 1,897 shares worth $942K. The position accounts for 0.01% of the portfolio, ranked #237.

Perpetual Ltd first reported a position in VRTX in Q2 2014 and has held it in 18 quarters since. The position peaked at $95.5M in Q1 2023. 368 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Perpetual Ltd held 1,897 shares of Vertex Pharmaceuticals worth $942K as of Q2 2026.
  • Perpetual Ltd bought 60 Vertex Pharmaceuticals shares in Q2 2026, an estimated $26.6K.
  • Vertex Pharmaceuticals made up 0.01% of Perpetual Ltd's portfolio in Q2 2026, its #237 holding.
  • Perpetual Ltd first reported a position in Vertex Pharmaceuticals in Q2 2014 and has held it in 18 quarters since.
  • Perpetual Ltd's Vertex Pharmaceuticals position peaked at $95.5M in Q1 2023.
  • 368 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.